Jonathan D Schoenfeld

21PUBLICATIONS
125CO-AUTHORS
Radiation therapyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 07, 2026
Risk-adapted therapy guided by human papillomavirus (HPV) circulating tumor DNA in HPV-positive oropharyngeal cancer (ReACT 1.0): an exploratory phase II trial.

|May 02, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancer.

|Dec 23, 2025
Automated Lymph Node and Extranodal Extension Assessment Improves Risk Stratification in Oropharyngeal Carcinoma.

Zezhong Ye, Reza Mojahed-Yazdi, Anna Zapaishchykova

|Sep 03, 2025
Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study.

Jean Bourhis, Lisa F Licitra, Barbara Burtness

|Dec 23, 2024
A Prospective Trial of Biomarker-Guided Surveillance for HPV-Positive Oropharynx Cancer Using Plasma Tumor Tissue-Modified Viral HPV DNA.

Eleni M Rettig, Jonathan D Schoenfeld, Julianna Miller

|Dec 13, 2024
Next-Generation Sequencing-Based MSI Scoring Predicts Benefit in Mismatch Repair-Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D.

Jonathan D Schoenfeld, Nilofer S Azad, Jacob Gross

Pageof 4

Frequent Collaborators

7 joint publications

Danielle N Margalit

6 joint publications

Roy B Tishler

5 joint publications

Robert I Haddad

5 joint publications

Ravindra Uppaluri